Ms Charlotte NGO

Adr:37 rue Rottembourg, 75012 Paris
Born in April 14th 1977 in Rennes (France)
Nationality: french
Mobile : 00.33.6.64.12.31.05
Married, 2 kids
E-mail : [email protected]
N° RPPS: 751750340 N° conseil de l’ordre : 75034

Position :

University Hospital Practitioner
Department of gynecological and breast cancers surgery
European Hospital Georges Pompidou, APHP
20 rue Leblanc, 75015 Paris

Last positions held 

November 2012 – April 2014: Specialist Practitioner of Cancer Comprehensive center, Department of Surgical Oncology, Institut Curie, Paris.

November 2008-November 2012: physician assistant specialist, Department of Surgical Oncology, Institut Curie, Paris, University Paris Descartes.

1. Curriculum vitae

1.0 Degrees
Academic qualifications

2014: Master Human Rights and Humanitarian Action, Global Health option, Paris School of International Affairs, Sciences Po.

2010: PhD in cell biology, thesis supported on 18/06/2010, University Paris Descartes.

2008: MD, thesis defended on 16/06/2008, Faculty of Medicine Paris VII-Denis Diderot.

2008: Diploma of Specialist in Obstetrics and Gynaecology, Faculty of Medicine Paris VII-Denis Diderot.

2007: Master 2 Surgical Sciences, Oncology option, Faculty of Medicine Kremlin Bicetre, Paris XI University.

2005: University Diploma of Perinatal Medicine, Faculty of Medicine Cochin, Paris V.

2004 Interuniversity Diploma of Ultrasound in obstetrics and gynecology and breast imaging, Faculty of Medicine, Créteil, Paris XII Val de Marne.

2001: Master of Biological and Medical Sciences, Faculty of Medicine Xavier Bichat, Université Paris VII.

1998: Certificate in biological and medical sciences Embryology, histology and molecular cytogenetics, C1, Faculty of Medicine Xavier Bichat, Université Paris VII.

1997: Certificate in biological and medical sciences in Cell Biology, C2, Faculty of Medicine Xavier Bichat, Université Paris VII.

1995 Baccalauréat S, with honors.

Hospital tracks

November 2012: Specialist Practitioner of Cancer Comprehensive center
November 2010: Assistant Practitioner Specialist, fellow University Paris-Descartes
November 2008: Assistant Practitioner Specialist
2001: Resident(rank 508, Range 9 in obstetrics and gynecology Paris)

1.1 Residency

November 2007: 10th semester internship in the Department of General Surgery and Gynecology Dr. Villet, Deaconess Hospital Group Croix Saint Simon, Paris.

May 2006: 9th semester internship in the Department of Surgery Dr. Salmon, Institut Curie, Paris.

May 2005: 8th semester internship in the Department of Gynecologic Surgery Prof. Chapron, Cochin Hospital Group, Saint Vincent de Paul, La Roche Guyon; Paris.

November 2004: 7th semester internship in the Department of Digestive Surgery and Transplantation Prof. Soubrane, Cochin Hospital Group, Saint Vincent de Paul, La Roche Guyon; Paris.

May 2004: 6th semester internship in the Department of Obstetrics and Gynecology Prof. Cabrol, Maternity Port-Royal, Cochin Hospital Group, Saint Vincent de Paul, La Roche Guyon; Paris.

November 2003: 5th semester internship in the Department of Obstetrics and Gynecology Prof. Paniel, Centre hospitalierintercommunal de Créteil.

May 2003: 4th semester internship in the department of gastrointestinal and urological surgery Dr. Estenne, Hôpital André Mignot, Versailles.

November 2002: 3rd semester internship in the Department of Obstetrics and Gynecology Dr. Saint Léger, André Grégoire Hospital, Montreuil.

May 2002: 2nd semester internship in the Department of Obstetrics and Gynecology Prof. Madelenat, Rothschild Hospital, Paris.

November 2001: 1st semester internship in the Department of Obstetrics and Gynecology Prof. Uzan, Hôpital Jean Verdier, Bondy.

1.2 Research

November 2006-October 2007: Master in Surgical Sciences, Immunology Laboratory of Prof. Weill and Pr.Batteux, EA1833, Hôpital Cochin, Paris Descartes faculty.

May 2008-November 2008: Full-time EA1833 Immunology laboratory for PhD thesis.

2. Publications

2.1 Original articles in journals with peer review

2014

F. Lécuru, AS. Bats, C. Bensaid, C. Ngo, N. Douay-Hauser, J. Seror, C. Nos, P. Combe, J. Medioni, E. Pujade-Lauraine. Surgery for ovarian cancer: the main principles still valid. Oncology (2014) 16: 313-316.

C. Ngo, C. Brugier, C. Floor, A. de la Rochefordière, S. Alran, JG. Feron, C. Malhaire, S.Scholl, X. Sastre, R. Rouzier and V. Fourchotte. Clinical pathology and prognosis of endometrial cancer in patients Previously Treated for breast cancer, with or without Tamoxifen: a comparative study in 363 patients. EJSO, 2014, in press.

2013

Hequet D Zarca K, Dolbeault S, Couturaud B, C Ngo, Fourchotte V, De La Rochefordière A, Feron JG, Fitoussi A, C Bélichard, Reyal F, Laki F, Hajage D, Sigal B, B Asselain, Alran S; Institut Curie Breast Cancer Group, Roman Rouzier. Reasons of not HAVING breast reconstruction: a historical cohort of 1937 breast cancer patients Undergoing mastectomy.
Springerplus. 2013 Jul 18; 2:325. doi: 10.1186/2193-1801-2-325.
C. Ngo, C. Abboud, P. Meria, V. Fourchotte, P. Mariani, B. Baranger, X. Sastre, C. Malhaire, AC Philip A. of Rochefordière, and S. Alran. Long term outcome and quality of life after pelvic exenteration for recurrent endometrial and cervical cancers. J ObstetGynecol Open 2013 vol 3 DOI: 10.4236/ojog.2013.35A1005.

FC.Bidard, L. Belin, S. Delaloge, F. Lerebours, C. Ngo, F. Reyal, S. Alran, S. Giacchetti, Marty, R. Lebofsky and JY. Pierga. Time dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: analysis of the 70 months REMAGUS02 study. International Journal of Breast Cancer, 2013, 2013:130470.

Vaysse C Sroussi J, Mallon P, Feron JG, Rivain AL, Ngo C, Bélichard C, Lasry S, Pierga JY, Couturaud B, Fitoussi A, Laki F, V Fourchotte, Alran S, Kirova Y, Vincent-Salomon A, Sastre-Garau X, Sigal-Zafrani B, Rouzier R, Reyal F. Prediction of axillary lymph node status in male breast carcinoma. Ann Oncol 2013 Feb; 24 (2): 370-6.

2012

C.Ngô, D. Mouttet, Y. De Rycke, F. Reyal, V. Fourchotte, F. Hugonnet, MC Falcou FC.Bidard, A. Vincent-Salomon, A. Fourquet, S. Alran. Over time validation of a nomogram to predict Including Her2 status the sentinel node positivity in early breast cancer.Eur J SurgOncol 3 September 2012. [Epub ahead of print].

2011

C. Ngo, S. Alran, C. Floor, V. Fourchotte, P. Petrow, M. Campitelli, S. Batwa, X. Sastre, RJ. Salmon, A. de la Rochefordière. Outcome Following in early cervical cancer pre-operative low dose rate brachytherapy: a ten years follow up of 257 patients at a single institution Treated. GynecolOncol 2011, November, 123 (2) :248-52.

C. Ngo, R. Villet, D. Salet-Lizée, P. Gadonneix. Rectocele repair-review and update. J Med Lebanon 2011Apr-Jun, 59 (2) :100-4.

Mr. Leconte, C. Nicco, C. Ngo, C. Chéreau, J. Guibourdenche, S. Arkwright, B. Weill, C. Chapron, B. Dousset and F. BatteuxThemTOR / Akt inhibitor temsirolimus deep infiltrating endometriosis Prevents in mice. Am J Pathol. 2011 Aug; 179 (2) :880-9. Epub 2011 Jun 12

C. Chapron, MC. Lafay-Pillet, E. Monceau, B. Borghese, C. Ngo, C.Souza, D. Ziegler. Questioning Concerning Adolescent patients’ history contains markers with deep infiltrating endometriosis Associated. FertilSteril 2011, March 1, 95 (3) :877-87.

2010

Ngo C, Nicco C, Leconte M, Chereau C, S. Arkwright, MC. Vacher-Lavenu, Weill B, C Chapron, F. Protein kinase inhibitors Batteux can control the progression of endometriosis in vitro and in vivo. Journal of Pathology, 2010, 222:148-57.

Ngo C, Kayem G, Habibi A, Benachi A, Goffinet F, Galactéros F, Haddad B. Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving send prophylactic partial exchange transfusions. Eur J ObstetGynecol 2010 October, 152 (2) :138-42.

L. Le Bourhis, E. Martin, I. Péguillet, N. Froux Mr. Korah, A. Guihot, V. MeyssonnierPremel V., C. Ngo, B. Riteau, L. Duban, D. Robert, M . Rottman, C. Soudais, O. Lantz. Specific anti-bacterial reactivity of Mucosal Associated Invariant T cells. Nature Immunology, 2010, 11 :701-8.

C. Chapron, C. Souza, D. Ziegler, MC. Lafay-Pillet, C. Ngo, G. Bijaoui, F. Goffinet, B. Borghese. Smoking habits in 411 women with histologically proven endometriosis and 567 unaffected controls.FertilSteril 2010 November, 94 (6) :2353-5.

Mr. Leconte, C. Nicco, C. Ngo, S. Arkwright, C. Chéreau, J. Guibourdenche, B. Weill, C. Chapron, B. Dousset, and FrédéricBatteux. Antiproliferative effect of cannabinoid agonists on deep infiltrating endometriosis American Journal of Pathology December 2010, 177 (6) :2963-70.

2009

Ngo C, Nicco C, Leconte M, Chereau C, Weill B, Batteux F, Chapron C. Antiproliferative effects of anastrozole, methotrexate and 5-fluorouracil on endometriosis in vitro and in vivo. FertilSteril 2009, 31 December.

Ngo C, Chereau C, Nicco C, Weill B, C Chapron, F. Reactive oxygen species Batteux control endometriosis progression. Am J Pathol 2009; 175 :225-234.

2008

Ngo C, Villet R: Unusual vulvar cystic mass Suspected metastasis. Pelviperineology 2008; 27:28.

Ngo C, Salet-Lizée D, P Gadonneix, Villet R. Preoperative clinical and complementary examinationsof pelvic floor disorders.Pelvipérinéologie 2008, 3: 204-213.

2007

C Ngo, AG Pollet, J Laperrelle, Ackerman G, S Gum, Thibault F, V Fourchotte, RJ Salmon. Intraoperative ultrasound localization of non-palpable breast cancers. Ann SurgOncol 2007, September, 14 (9) :2485-9.

Ngo C, G Viot, Aubry MC, V Tsatsaris, Grange G, Cabrol D, E Pannier. First trimester ultrasonographic diagnosis of skeletal dysplasia Increased nuchal translucency with Associated. Ultrasound ObstetGynecol, 2007 Aug, 30 (2) :221-6. Review.

2.2 Other Publications

C. Ngo. Breast cancer: what’s new? Surgery.Réalités en gynécologie et obstétrique, May 2012, 162: 29-32.

2.3 Communications in congress

Posters

C. Ngo, Y. De Rycke, C. Bélichard, N. Guilhen, V. Doridot, R. Rouzier, C. Coutant, D. Hudry, X. Fritel, V. Fourchotte, JG. Feron, JY. Pierga, A. Vincent-Salomon, and S. Alran.
The Institut Curie Including HER2 status Nomogram Predicts additional axillary metastasis in breast cancer patients with a positive sentinel node biopsy: a multicentric validation. San Antonio Breast Cancer Symposium, December 2012, San Antonio, Texas, USA.

Mr. Valentin, Queinnec, V. Fourchotte, C. Ngo, Feron JG, AL Rivain, V. De Margerie, MC Falcou, Slavomir P., S. Alran. How Long Does a surgeon need to change his (her) practice in breast surgery? SFSPM November 2012, Paris.

N. Lesage, B. Buecher, C. Floor, JG Feron, V. Fourchotte, C. Ngo, P. Cotta, S. Scholl, C. Malhaire, C. Houdayer, A. Vincent-Salomon, X. Sastre, B . Asselain, D. Stoppa-Lyonnet, S. Alran. Prognostic impact of BRCA status and risk calculation BOADICEA patients treated for epithelial ovarian cancer. CETA, September 2012, Paris.

C. Abboud, C. Ngo, P. Meria, V. Fourchotte, P. Mariani, B. Baranger, P. Petrow, X. Sastre, P. Cotta, the Rochefordière A., and S. Alran.Outcome of pelvic exenteration for recurrent endometrial and cervical cancers. ASCO, Chicago June 2012 abstract for e-publication only e15524.

Hequet D Zarca K, Dolbeault S, V Fourchotte, Couturaud B Reyal F, Malka I, Ngo C, Feron JG, Laki F, De La Rochefordière A, B Sigal, Asselain B, D Hajage, Alran S. Medical and personalized Reasons of no mastectomy breast reconstruction Effective: results in 1,937 breast cancer patients with 70% of no reconstruction in a single cancer institute. EBCC, Vienna, March 2012.

Gaujal L, M Queinnec, Malka I, Feron JG, Ngo C, Fourchotte V, Salmon JR, De Margerie V, Mariani P, MC Falcou, Hugonnet F, Esteve M, Alran S. Feasibility of sentinel lymph node detection with radioisotopic method alone Effective a grade IV anaphylactic reaction to Patent Blue in breast cancer surgery. EBCC, Vienna, March 2012.

Ngo C, De Rycke Y, Mouttet D, F Reyal, Fourchotte V Hugonnet F, Falcou MC Bidard FC, ​​Vincent-Salomon A, Fourquet A, Sigal-Zafrani B, and S Alran. Validation of a nomogram over time Predicting the sentinel node positivity in early breast carcinoma ACCORDING to the molecular subtypes classification. San Antonio Breast Cancer Symposium, December 6-10, 2011 San Antonio, Texas, USA. French company Sénologie and Breast Pathology, November 2011, Marseille. Post discussion and oral communication.
C.Ngô, Y. De Rycke, C. Castellier, V. Fourchotte, F. Hugonnet, D. Hajage, F. Reyal, A. Vincent-Salomon, JY. Pierga, Y. Kirova, X. Sastre-Garau and S. Alran. Prediction of additional nodal metastasis in breast cancer patients with a positive sentinel node biopsy: a new nomogram Including HER2 status. San Antonio Breast Cancer Symposium, December 6-10, 2011 San Antonio, Texas, USA. French company Sénologie and BreastPathology, November 2011, Marseille.
C.Ngô, S.Alran, C.Plancher, V.Fourchotte, D. Hajage, P.Petrow, JG. Feron, M.Campitelli, X.Sastre, V. De Margerie, S. and A. Scholl of Rochefordière. Predicting response to pre-operative low dose rate brachytherapy in cervical carcinoma early: a clinical-biological score to select eligible patients. European Society of Gynecological Oncology, Milan, September 2011.

Fourchotte V., C. Brugier, JG. Feron, C. Ngo, C. Floor, A. de la Rochefordière, P. Cotta, P. Petrow, X. Sastre, B. Asselain, S. Alran. Effective breast cancer endometrial cancer and Its relationship with tamoxifen. European Society of GynecologicalOncology, Milan, September 2011.

V. Fourchotte, B. Renevier, the Rochefordière A., F. Laki, C. Ngo, X. Sastre, C. Rousset-Jablonski, D. Stoppa-Lyonnet, P. This, MC. Falcou, A. Savignoni, S. Alran. Risk-reducing salpingo-oophorectomy, 10 year experience at Institut Curie. European Society of Gynecological Oncology, Milan, September 2011.
C.Ngô, S.Alran, S.Batwa, C.Plancher, V.Fourchotte, X.Sastre, P.Petrow, M.Campitelli, RJ.Salmon, P.Cottu, and A. Larochefordière. Prediction of pathological response in early cervical carcinoma Effective pre-operative low dose rate brachytherapy: results in 257 patients Treated at Institut Curie. European Society of Surgical Oncology, Bordeaux, September 2010.

Cagnat J., S. Alran, A. Savignoni, JY. Pierga, C. Ngo, V. De Margerie, Y. Kirova, C. Gautier, A.VincentSolomon, RJ. Salmon, for the Institute Curie Breast Cancer Study Group – B. Sigal-Zafrani. Predictive negative axillary dissection factoring of neoadjuvant chemotherapy Effective (NAC) instead of a score in decision-making Regarding sentinel lymph node in patients with NAC Effective locally advanced breast cancer. European Breast Cancer Conference, 24-27 March 2010, Barcelona, Spain.

I Iurisci, Cottu P, C Ngo, M Lae, JY Pierga, V Diéras, Sigal-Zafrani B, Kirova Y, L Mignot, A Vincent Solomon, On Behalf of the Institut Curie Breast Cancer Group. Heterogeneous amplification of HER2 is a clinically significant unusual goal invasive ductal carcinoma in event. San Antonio Breast Cancer Symposium, December 9-13, 2009 San Antonio, Texas, USA.

Ngo C, Pollet AG, Laperrelle J Ackerman G, Gum S, Thibault F, Fourchotte V, Salmon RJ.Intraoperative ultrasound localization of non-palpable breast cancers. Society of Surgical Oncology Annual Meeting, Washington DC, March 2007. Eurocancer, Paris, June 2007. San Antonio Breast Cancer Symposium, San Antonio, December 2007.

C. Ngo, G. Kayem, A. Benachi, Y. Dumez, A. Habibi, F. Goffinet, D. Cabrol, F. Galactéros, B. Haddad.Pregnancy in sickle cell disease: results of a multicenter survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Society for Maternal-Fetal Medicine 27th Annual Scientific Meeting, San Francisco, February 2007.

Οral communications

The use of the artificial dermis Integra ® combined with negative pressure wound therapy to treat chronic defects in patients with breast cancer. Middle East Wounds and Scar Meeting, Dubai March 2014

Long term outcome and quality of life after pelvic exenteration for recurrent endometrial and cervical cancers.International Gynecological Cancer Society, October 2012, Vancouver, Canada.

Over time validation of a nomogram sentinel node positivity Predicting the in early breast carcinoma according to the molecular subtypes classification. San Antonio Breast Cancer Symposium, December 6-10, 2011 San Antonio, Texas, USA. Société Française de Sénologie et de Pathologie Mammaire, November 2011, Marseille. Poster discussion and oral communication.

Sickle cell disease and pregnancy: multicenter study of the effect of prophylactic transfusion on maternal and fetal vascular disease. SEHTAG, 13 October 2006, Paris.

Ultrasound diagnosis osteochondrodysplasias 1st trimester of pregnancy.Soirée d’échographie d’Esquirol, February 2005, Saint Maurice.

Polyarteritisnodosa and pregnancy: report of a case. French Society of Gynecology and Obstetrics, December 2004, Paris.

2.3 Invitations as speaker in conferences / seminars / workshop

Conservative surgery in gynecological cancers.HEGP, June 18, 2014, Paris.

Ambulatory surgery in breast cancer, Salon de gynécologiepratique, February 2014, Paris.

Indications of oncoplasty To Avoid mastectomy. Breast Cancer Workshop, latest Developments, surgical treatment and reconstruction, Athens November 2013

Surgical management of the axilla in early breast cancer. Breast Cancer Workshop, latest Developments, surgical treatment and reconstruction, Athens November 2013

Management of cervical cancer of the uterus. 11th Congress of French Gynecologists Beirut, 29-30 April 2011

News on the management of ovarian cancer. 11th Congress of French Gynecologists Beirut, 29-30 April 2011

Peritoneum and infertility: pathophysiology news. Days FFER, session of the CTIS, 18 September 2008, Paris.

2.4 Public Health Activities

Humanitarian mission from November 2005 to March 2006, humanitarian mission with Médecins Sans Frontières in obstetrics and gynecologic surgery in Monrovia, Liberia.

3 Further information
Memoirs

The International Criminal Court and the United States. Master Thesis: Human Rights and Humanitarian Action, Paris School of International Affairs, Sciences Po Paris, led by Mr Olivier Barrat.

Role of reactive oxygen species in the proliferation of endometriotic cells in vitro and in viso: therapeutic applications. PhD thesis, Cell Biology option, led by Dr. Batteux, EA1833 Immunology Laboratory headed by Dr. Weill, University Paris Descartes.

Sickle cell disease and pregnancy: study of maternal and fetal morbidity in a population receiving prophylactic transfusions. MD thesis, led by Dr. Kayem, Centre hospitalierintercommunal de Créteil.

In vitro and in vivo study of the role of reactive oxygen species in the proliferation of endometriotic cells.Involvement in the medical treatment of endometriosis. Master thesis of Surgical Sciences, led by Dr. Batteux, EA1833 Immunology Laboratory headed by Dr. Weill, University Paris Descartes.

Intraoperative ultrasound marking of non-palpable breast cancers.Memoir for the diploma of specialist in obstetrics and gynecology, led by Dr. Salmon, Institut Curie, Paris.

Ultrasound diagnosis of osteochondrodysplasiasduring the 1st trimester of pregnancy.Memoir for the university diploma of ultrasound in obstetrics gynecology and breast imanging, led by Dr. Pannier, Maternity Port-Royal, Paris.

Trial

BioRaids: principal investigator and coordinator for France of the BioRaids protocol: European multicenter trial aimed at identifying molecular abnormalities in cervical cancer. (European funding)